Loading company details...
Beta
Latest Form 4 (Nov 15, 2024): Jane E. Kiernan (Director): Disposition to Issuer of 19,861 shares, $1.41M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 15, 2024 | Jane E. Kiernan | Disposition to Issuer | 19,861 | $1.41M |
| Nov 15, 2024 | John Woock, EVP, Chief Mktg/Strtgy Officer | Disposition to Issuer | 77,403 | $5.50M |
| Nov 15, 2024 | Nancy Lynn Snyderman Md. | Disposition to Issuer | 14,944 | $1.06M |
| Nov 15, 2024 | Rinda Sama, Chief Operating Officer | Disposition to Issuer | 83,854 | $5.95M |
| Nov 15, 2024 | Karen Noblett, Chief Medical Officer | Disposition to Issuer | 34,428 | $2.44M |
| Nov 15, 2024 | Robert McNamara | Disposition to Issuer | 14,861 | $1.06M |
| Nov 15, 2024 | Esteban Lopez | Disposition to Issuer | 6,600 | $468.6K |
| Nov 15, 2024 | Kari Leigh Keese, Chief Financial Officer | Disposition to Issuer | 40,362 | $2.87M |
| Nov 15, 2024 | Alfred J. Ford Jr., Chief Commercial Officer | Disposition to Issuer | 43,450 | $3.08M |
| Nov 15, 2024 | David M. Demski | Disposition to Issuer | 9,542 | $677.5K |